Have a personal or library account? Click to login
Neuroimaging Assessment of Nigrosome 1 with a Multiecho Gre Magnetic Resonance Sequence in the Differentiation Between Parkinson’s Disease from Essential Tremor and Healthy Individuals Cover

Neuroimaging Assessment of Nigrosome 1 with a Multiecho Gre Magnetic Resonance Sequence in the Differentiation Between Parkinson’s Disease from Essential Tremor and Healthy Individuals

Tremor and Other Hyperkinetic Movements
Volume 11 (2021): Issue 1
By: Gabriel Henrique Almeida Antonio Bienes,  Caroline de Pietro Franco Zorzenon,  Ernesto Duarte Alves,  Luís Antônio Tobaru Tibana,  Vanderci Borges,  Henrique Carrete Junior and  Henrique Ballalai Ferraz  
Open Access
|May 2021

References

  1. 1Gibb WRG, Lees AJ. The Significance of the Lewy Body in the Diagnosis of Idiopathic Parkinson’s Disease. Neuropathol Appl Neurobiol. 1989; 15(1): 27–44. DOI: 10.1111/j.1365-2990.1989.tb01147.x
    Back to article
  2. 2Louis ED. Essential Tremor. Arch Neurol. 2000; 57: 1522–1524. DOI: 10.1001/archneur.57.10.1522
    Back to article
  3. 3Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G. Accuracy of clinical diagnosis of Parkinson disease. Neurology. 2016; 86(6): 566–576. DOI: 10.1212/WNL.0000000000002350
    Back to article
  4. 4Caslake R, Moore JN, Gordon JC, Harris CE, Counsell C. Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism. J Neurol Neurosurg Psychiatry. 2008; 79(11): 1202–1207. DOI: 10.1136/jnnp.2008.144501
    Back to article
  5. 5Blazejewska AI, Schwarz ST, Pitiot A, Stephenson MC, Lowe J. Visualization of nigrosome 1 and its loss in PD. Neurology. 2013; 81. DOI: 10.1212/WNL.0b013e31829e6fd2
    Back to article
  6. 6Schwarz ST, Afzal M, Morgan PS, Bajaj N, Gowland PA, Auer DP. The “swallow tail” appearance of the healthy nigrosome – A new accurate test of Parkinson’s disease: A case-control and retrospective cross-sectional MRI study at 3T. PLoS One. 2014; 9(4). DOI: 10.1371/journal.pone.0093814
    Back to article
  7. 7Jin L, Wang J, Wang C, et al. Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and de novo Parkinson’s Disease. Front Neurol. 2019; 10(February): 1–8. DOI: 10.3389/fneur.2019.00100
    Back to article
  8. 8Perez Akly MS, Stefani CV, Ciancaglini L, et al. Accuracy of nigrosome-1 detection to discriminate patients with Parkinson’s disease and essential tremor. Neuroradiol J. 2019. DOI: 10.1177/1971400919853787
    Back to article
  9. 9Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain: I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D 28K immunohistochemistry. Brain. 1999; 1421–1436. DOI: 10.1093/brain/122.8.1421
    Back to article
  10. 10Massey LA, Miranda MA, Al-Helli O, et al. 9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease. NeuroImage Clin. 2017; 13: 154–163. DOI: 10.1016/j.nicl.2016.11.015
    Back to article
  11. 11Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain. 1999; 1437–1448. DOI: 10.1093/brain/122.8.1437
    Back to article
  12. 12Hirsch EC, Brandel J-P, Galle P, Javoy-Agid F, Agid Y. Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson’s Disease: An X-Ray Microanalysis. J Neurochem. 1991; 56(2): 446–451. DOI: 10.1111/j.1471-4159.1991.tb08170.x
    Back to article
  13. 13Dexter DT, Wells FR, Lee AJ, et al. Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson’s Disease. J Neurochem. 1989; 52(6): 1830–1836. DOI: 10.1111/j.1471-4159.1989.tb07264.x
    Back to article
  14. 14Schwarz ST, Mougin O, Xing Y, et al. Parkinson’s disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI. NeuroImage Clin. 2018 April; 19: 683–689. DOI: 10.1016/j.nicl.2018.05.027
    Back to article
  15. 15Ordidge RJ, Gorell JM, Deniau JC, Knight RA, Helpern JA. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med. 1994; 32(3): 335–341. DOI: 10.1002/mrm.1910320309
    Back to article
  16. 16Postuma RB, Berg D, Stern M, et al. UC San Diego UC San Diego Previously Published Works Title MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015; 30(12): 1591–1601. DOI: 10.1002/mds.26424
    Back to article
  17. 17Bhatia KP, Bain P, Bajaj N, et al. Consensus Statement on the classification of tremors. From the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018; 33(1): 75–87. DOI: 10.1002/mds.27121
    Back to article
  18. 18Haerer AF, Anderson DW, Schoenberg BS. Prevalence of Essential Tremor: Results From the Copiah County Study. Arch Neurol. 1982; 39(12): 750–751. DOI: 10.1001/archneur.1982.00510240012003
    Back to article
  19. 19Von Campenhausen S, Bornschein B, Wick R, et al. Prevalence and incidence of Parkinson’s disease in Europe. Eur Neuropsychopharmacol. 2005; 15(4): 473–490. DOI: 10.1016/j.euroneuro.2005.04.007
    Back to article
  20. 20Andrade ALSS, Zara AL de SA. Métodos de investigação epidemiológica em doenças transmissíveis. Organ Pan-americana da Saúde Fundação Nac Saúde. 1998; II: 135.
    Back to article
  21. 21Noh Y, Sung YH, Lee J, Kim EY. Nigrosome 1 detection at 3T MRI for the diagnosis of early-stage idiopathic Parkinson disease: Assessment of diagnostic accuracy and agreement on imaging asymmetry and clinical laterality. Am J Neuroradiol. 2015; 36(11): 2010–2016. DOI: 10.3174/ajnr.A4412
    Back to article
  22. 22Fearnley JM, Lees AJ. Ageing and Parkinson’s Disease: Substantia Nigra Regional Selectivity. 1991; 2283–2301. DOI: 10.1093/brain/114.5.2283
    Back to article
  23. 23Barber TR, Griffanti L, Bradley KM, et al. Nigrosome 1 imaging in REM sleep behavior disorder and its association with dopaminergic decline. Ann Clin Transl Neurol. 2020; 7(1): 26–35. DOI: 10.1002/acn3.50962
    Back to article
  24. 24Benamer HTS, Patterson J, Grosset DG, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study group. Mov Disord. 2000; 15(3): 503–510. DOI: 10.1002/1531-8257(200005)15:3<;503::AID-MDS1013>3.0.CO;2-V
    Back to article
  25. 25Stockner H, Wurster I. Transcranial Sonography in Essential Tremor. Vol 90. Elsevier Inc.; 2010. DOI: 10.1016/S0074-7742(10)90014-7
    Back to article
  26. 26Kim JY, Illigens BMW, McCormick MP, Wang N, Gibbons CH. Alpha-synuclein in skin nerve fibers as a biomarker for alpha-synucleinopathies. J Clin Neurol. 2019; 15(2): 135–142. DOI: 10.3988/jcn.2019.15.2.135
    Back to article
  27. 27Novellino F, Arabia G, Bagnato A, et al. Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors. Mov Disord. 2009; 24(15): 2242–2248. DOI: 10.1002/mds.22771
    Back to article
  28. 28Benito-León J, Louis ED, Bermejo-Pareja F. Risk of incident Parkinson’s disease and parkinsonism in essential tremor: A population based study. J Neurol Neurosurg Psychiatry. 2009; 80(4): 423–425. DOI: 10.1136/jnnp.2008.147223
    Back to article
  29. 29Hopfner F, Ahlf A, Lorenz D, Klebe S, Zeuner KE. Early- and Late-Onset Essential Tremor Patients Represent Clinically Distinct Subgroups. 2016; 1–8. DOI: 10.1002/mds.26708
    Back to article
  30. 30He N, Ling H, Ding B, et al. Region-specific disturbed iron distribution in early idiopathic Parkinson’s disease measured by quantitative susceptibility mapping. Hum Brain Mapp. 2015; 36(11): 4407–4420. DOI: 10.1002/hbm.22928
    Back to article
  31. 31Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014; 13(10): 1045–1060. DOI: 10.1016/S1474-4422(14)70117-6
    Back to article
  32. 32Novellino F, Cherubini A, Chiriaco C, et al. Brain iron deposition in essential tremor: A quantitative 3-tesla magnetic resonance imaging study. Mov Disord. 2013; 28(2): 196–200. DOI: 10.1002/mds.25263
    Back to article
  33. 33Cheng Z, He N, Huang P, et al. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson’s disease. NeuroImage Clin. 2020; 25(October 2019): 102103. DOI: 10.1016/j.nicl.2019.102103
    Back to article
DOI: https://doi.org/10.5334/tohm.604 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Jan 29, 2021
Accepted on: Apr 10, 2021
Published on: May 18, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Nigrosome,
MRI,
Parkinson Disease,
Essential Tremor

© 2021 Gabriel Henrique Almeida Antonio Bienes, Caroline de Pietro Franco Zorzenon, Ernesto Duarte Alves, Luís Antônio Tobaru Tibana, Vanderci Borges, Henrique Carrete Junior, Henrique Ballalai Ferraz, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 11 (2021): Issue 1Next article